Recent Updates
Recently added Catalysts
RIGL Positive Sentiment Score: 70/100

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Friday, October 4, 2024 1 min read
Key Takeaway: Rigel Pharmaceuticals, Inc. announced the granting of 35,944 stock options to fifteen non-executive employees as part of its Inducement Plan. This initiative, approved by Rigel's Board of Directors, is designed to incentivize new hires in accordance with NASDAQ Listing Rule 5635(c)(4). The stock options will vest over a period of four years, with a one-year cliff. Rigel is focused on developing novel therapies for patients with hematologic disorders and cancer.

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel granted stock options to attract new employees, showing growth.
  • The inducement plan reflects Rigel's commitment to talent acquisition.
  • Granting stock options aligns with the company's long-term strategic goals.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Oct. 4, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to Rigel's Inducement Plan, approved by the Compensation Committee of Rigel's Board of Directors and granted as an inducement material to employees' entering into employment with Rigel, in accordance with NASDAQ Listing Rule 5635(c)(4). Specifically, Rigel granted 35,944 stock options to fifteen non-executive employees vesting over four years with a one-year cliff.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media
Rigel Pharmaceuticals, Inc.
SOURCE Rigel Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

What recent awards did Rigel Pharmaceuticals announce?

Rigel announced the grant of 35,944 stock options to fifteen non-executive employees.

What is the vesting schedule for Rigel's stock options?

The stock options vest over four years with a one-year cliff.

What is the purpose of Rigel's Inducement Plan?

The Inducement Plan aims to incentivize employees upon joining the company.

When was Rigel Pharmaceuticals founded?

Rigel Pharmaceuticals was founded in 1996.

Where is Rigel Pharmaceuticals located?

Rigel Pharmaceuticals is based in South San Francisco, California.

Tags: RIGL Viatris Investor Conferences Healthcare Rigel Pharmaceuticals NASDAQ Inducement Plan stock options
Last updated: Oct 4, 2024